Testosterone in Metastatic Renal Cell Carcinoma Patients

Clinical trial NCT03379012 · COMPLETED

Trial details

NCT number: NCT03379012
Sponsor: Kidney Cancer Research Bureau
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2016-02-08
Primary completion: 2018-01-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.